Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DirectACCESS Medical is a U.S. medical device company focused on dialysis access and peripheral intervention products. The company is best known as the developer of the FirstChoice UHP PTA balloon catheter line, designed for high-pressure angioplasty in tortuous dialysis access anatomy and for treatment of obstructive lesions in arteriovenous fistulae. Available public descriptions position the business as a small, privately held medtech company rather than a therapeutics developer. Its core activity appears to center on commercialization of interventional balloon catheter products for dialysis access procedures, with product visibility today largely through the FirstChoice brand in the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DirectACCESS Medical.